Doyle G P, Major D, Chu C, Stankiewicz A, Harrison M L, Pogany L, Mai V M, Onysko J
Breast Screening Program for Newfoundland and Labrador, St. John's, Canada.
Chronic Dis Inj Can. 2011 Sep;31(4):152-6.
Participation rate is an important indicator for a screening program's effectiveness; however, the current approach to measuring participation rate in Canada is not comparable with other countries. The objective of this study is to review the measurement of screening mammography participation in Canada, make international comparisons, and propose alternative methods.
Canadian breast cancer screening program data for women aged 50 to 69 years screened between 2004 and 2006 were extracted from the Canadian Breast Cancer Screening Database (CBCSD). The fee-for-services (FSS) mammography data (opportunistic screening mammography) were obtained from the provincial ministries of health. Both screening mammography program participation and utilization were examined over 24 and 30 months.
Canada's screening participation rate increases from 39.4% for a 24-month cut-off to 43.6% for a 30-month cut-off. The 24-month mammography utilization rate is 63.1% in Canada, and the 30-month utilization rate is 70.4%.
Due to the differences in health service delivery among Canadian provinces, both programmatic participation and overall utilization of mammography at 24 months and 30 months should be monitored.
参与率是筛查项目有效性的一项重要指标;然而,加拿大目前衡量参与率的方法与其他国家不具可比性。本研究的目的是回顾加拿大乳腺钼靶筛查参与率的测量方法,进行国际比较,并提出替代方法。
从加拿大乳腺癌筛查数据库(CBCSD)中提取2004年至2006年间接受筛查的50至69岁女性的加拿大乳腺癌筛查项目数据。服务收费(FSS)乳腺钼靶数据(机会性筛查乳腺钼靶)来自各省卫生部门。在24个月和30个月的时间里对乳腺钼靶筛查项目的参与情况和利用率进行了检查。
加拿大的筛查参与率从以24个月为截止期的39.4%升至以30个月为截止期的43.6%。加拿大24个月的乳腺钼靶利用率为63.1%,30个月的利用率为70.4%。
由于加拿大各省卫生服务提供情况存在差异,应监测24个月和30个月时乳腺钼靶检查的项目参与情况和总体利用率。